Download presentation
Presentation is loading. Please wait.
Published byMaurice Crawford Modified over 9 years ago
1
WP11: Modelling and simulation for NND Thomas Geijtenbeek, Frans van der Helm Delft University of Technology Amsterdam – 23-24 February 2015
2
Status of the WP T11.1 Construction of a scalable mass distribution model – Literature study on sensitivity of scaling methods – Process results from joint center calibration Amsterdam – 23-24 February 2015
3
Status of the WP T11.2 Development of a personalized disease specific skeletal model – Functional calibration Find joint rotation centers and axes Scale segment lengths Scale segment weights – MRI recordings Muscle volume – Physiological Cross-Sectional Area – Muscle optimum length from cadaver studies & scaled Via points – muscle attachments – Finally through Statistical State Model Amsterdam – 23-24 February 2015
4
Scaled musculoskeletal models Constructing a scaled model Brussels – 6-7 May 2014 Functional joint center calibration
5
Status of the WP T11.3 Construction of a disease specific muscle model – Plan to include spasticity model from VUMC (Van der Krogt et al.) – Muscle constraints: » Contractures: Passive constraints » Aberrant reflexes: low threshold on muscle contraction velocity reflex Amsterdam – 23-24 February 2015
6
Spastic controller: increased stretch reflex (vdKrogt et al., 2015) If: Stretch velocity of muscle fibers > Threshold Then: Spastic excitation ( t + Delay ) = Gain * stretch velocity … lead to efferent impulses causing contraction Afferent impulses from spinal cord… Threshold: extracted from data Delay: fixed to 30 ms Gain: individually tuned (0-4) METHODS
7
Force-length curves - with optimal stiffness parameters Cerebral Palsy (CP) vs Typically Developing (TD) vdKrogt et al. (2015) 0.511.5 0 0.5 1 1.5 Relative fiber length Relative fiber force Active Default passive TD hamstrings CP hamstrings TD vasti CP vasti RESULTS
8
Status of the WP T11.4 Design of models driven by the dynamics of gait perturbations – OpenSim model (available) Gait2392 model – 23 DOF – 92 musculotendon actuators representing 76 muscles To be adapted by available gait and morphological data – Optimization toolbox (connected) Covariance matrix adaptation (CMA) – Neural control signal, feedback parameters – Unknown model parameters – Predictive simulations (in progress) Optimization – Simulate optimal neural control model in pathological state » Mimick pathological gait – Predict optimal neural control after therapeutic intervention » Prediction of outcome after intervention and rehabilitation practice – Use gait data + EMG for validation Amsterdam – 23-24 February 2015
9
Predictive Simulations Find optimal gait pattern for any given musculoskeletal model Use high-level optimization criteria – Target speed – Metabolic energy expenditure Method does not require motion capture data – Can be used for validation Can incorporate neuromuscular deficiencies Amsterdam – 23-24 February 2015
10
Adapt to Model Scaling Amsterdam – 23-24 February 2015
11
The Optimization Process Amsterdam – 23-24 February 2015
12
Adapt to Target Speed Amsterdam – 23-24 February 2015
13
Find Optimized Muscle Attachments Amsterdam – 23-24 February 2015
14
What we are going to present to the EC (Annual review) Significant results Use cases Amsterdam – 23-24 February 2015
15
Current open issues Issues/criticalities Corrective actions Amsterdam – 23-24 February 2015
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.